TIME TO INTRAVENOUS THERAPY AND CLINICAL OUTCOMES IN OLDER PATIENTS PRESENTING WITH ACUTE DECOMPENSATED HEART FAILURE: AN ANALYSIS OF THE ADHERE REGISTRY EMERGENCY MODULE
Yee Weng Wong(Flinders Medical Centre), Adrian F. Hernandez(Duke University), Laura G. Qualls(Durham University), Roger M. Mills(Janssen (Belgium)), Gregg C. Fonarow(UCLA Medical Center), Xiaojuan Mi(Clinical Research Institute), Frank Peacock(Clinical Research Institute), Lesley H. Curtis(Duke University), Winslow Klaskala(Johnson & Johnson (United States))
Cited by 2
Related Papers
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k
Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
|American Heart Journal|2005|2.1k
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
|Circulation|2006|2.1k
The Global Health and Economic Burden of Hospitalizations for Heart Failure
|Journal of the American College of Cardiology|2014|2k